The Latest Breaking News from AstraZeneca

AstraZeneca said Monday its experimental pill lowered "bad" LDL cholesterol by 51%. But AstraZeneca stock fell in line with pharma stocks.

Pharma company will invest money over five years in ‘strategic partnership’ after ditching UK expansion

"It's like being drained of vitality." Scientists discovered a new syndrome linked to the COVID-19 vaccines that may cause persistent biological changes and chronic flu-like symptoms. The post Yale Scientists Link Covid Vaccines To Alarming New Syndrome With Long-Term Effects first appeared on Bored Panda.

The Cambridge-based pharmaceutical company behind a variety of medicines paid its chief executive Pascal Soriot £14.7 million in 2024.

The pharmaceutical and biotech industries are brimming with potential. From revolutionary cancer treatments to cutting-edge gene-editing breakthroughs, start-ups in this space have the power to transform medicine and save lives.

When the pharma firm cancelled plans for a major expansion of its Merseyside plant last month, there was no shortage of questions – or blame – over responsibility

AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate Devlin question why it fell through

London’s blue-chip index smashed through recent highs after experts said the Bank’s announcement gave it ‘a shot of adrenaline’.

AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.